Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 540NIH 170NETWORK 139INDUSTRY 43OTHER_GOV 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Filgrastim × Clear all
NCT01164345 2015-12-03

Mozobil for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 2 Completed
20 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02275663 2015-01-06

Azacytidine Plus FLAG for Relapsed or Refractory AML

King Fahad Medical City

Phase 2 Unknown
37 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00557102 2012-12-11

ERBIFORT

National Cancer Institute, France

Phase 2 Completed
24 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡